Ken Griffin Turning Point Therapeutics, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$24.32 - $75.3 $16.1 Million - $49.8 Million	-661,192 Reduced 79.97%	165,650 $12.5 Million
Q1 2022 May 16, 2022	BUY	$24.73 - $51.25 $4.47 Million - $9.26 Million	180,616 Added 27.95%	826,842 $22.2 Million
Q4 2021 Feb 14, 2022	BUY	$35.48 - $67.33 $14.3 Million - $27.2 Million	404,278 Added 167.09%	646,226 $30.8 Million
Q3 2021 Nov 15, 2021	BUY	$61.0 - $81.99 $14.3 Million - $19.3 Million	234,856 Added 3311.56%	241,948 $16.1 Million
Q2 2021 Aug 16, 2021	SELL	$62.93 - $90.59 $6.1 Million - $8.78 Million	-96,894 Reduced 93.18%	7,092 $553,000
Q1 2021 May 17, 2021	BUY	$88.19 - $140.01 $8.61 Million - $13.7 Million	97,652 Added 1541.71%	103,986 $9.84 Million
Q4 2020 Feb 16, 2021	SELL	$87.69 - $130.94 $8.45 Million - $12.6 Million	-96,388 Reduced 93.83%	6,334 $772,000
Q3 2020 Nov 16, 2020	BUY	$56.99 - $89.33 $2.93 Million - $4.6 Million	51,481 Added 100.47%	102,722 $8.97 Million
Q2 2020 Aug 14, 2020	BUY	$39.94 - $70.39 $1.57 Million - $2.77 Million	39,328 Added 330.13%	51,241 $3.31 Million
Q1 2020 May 15, 2020	SELL	$32.02 - $66.17 $1.08 Million - $2.23 Million	-33,628 Reduced 73.84%	11,913 $532,000
Q2 2019 Aug 14, 2019	BUY	$26.67 - $43.63 $1.21 Million - $1.99 Million	45,541 New	45,541 $1.85 Million

About Turning Point Therapeutics, Inc.

Ticker TPTX
Exchange NASDAQ
Shares Outstandng 50,074,300

More about TPTX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.